nk-cells

Documents about nk-cells

• BaEV-pseudotyped lentiviral vectors enable stable CAR expression and cytotoxic function in NK cells#214339PLOS
• Latent cytomegalovirus disrupts innate NK cell responses to <i>P. falciparum</i> and impairs parasite control in first infection in adults#305600PLOS
• scHG: A supercell framework with high-order graph learning enables scalable multi-omics analysis#158303PLOS
• CAR-NK Cells (CL-NK-001) in Pancreatic Cancer#1101410ClinicalTrials.gov
• CAR-NK Cells (CL-NK-003) in Pancreatic Cancer#1128321ClinicalTrials.gov
• Serum cholinesterase as a biomarker for sepsis-associated immunosuppression via Hub gene RORA#160487PLOS
• Single-cell transcriptomic analysis reveals the immunosuppressive status of NK cell subpopulations in TNBC#396689PLOS
• Clinical Study of NK Cells in the Treatment of Severe Endometriosis#1197279ClinicalTrials.gov
• Dual-Target CSPG4/GD2 CAR-NK Cells for Advanced Melanoma#1464455ClinicalTrials.gov
• NK Cells Infusion for Advanced Malignancies#363593ClinicalTrials.gov
• CD123-CD16-NK Cells Immunotherapy for AML#390933ClinicalTrials.gov
• Allogeneic PB103 (NK Cells) Therapy in Non-small Cell Lung Cancer (NSCLC) Patients#1375251ClinicalTrials.gov
• Intratumoral CD3+ and NKp46+ Cells in Colorectal Liver Metastases#1322242ClinicalTrials.gov
• Haploidentical Natural Killer (NK) Cells in Patients With Relapsed or Refractory Neuroblastoma#1125566ClinicalTrials.gov
• Dual-Target Nectin-4/HER2 CAR-NK Cells in Advanced Urothelial Carcinoma#1446027ClinicalTrials.gov
• Alloreactive Haploidentical Natural Killer (NK) Cells With Busulfan and Fludarabine/ATG#1214685ClinicalTrials.gov
• NK Cell Therapy for AML#806149ClinicalTrials.gov
• IL37,Tlymphocytes,NK Cells in Pathogenesis of ITP#1088019ClinicalTrials.gov
• MİR-30c ile stimüle edilmiş NK-92 hücrelerinin PC3 prostat kanseri hücreleri üzerindeki etkisi#620852Necmettin Erbakan University Institutional Repository
• Immunotherapy of Neuroblastoma Patients Using a Combination of Anti-GD2 and NK Cells#1212780ClinicalTrials.gov
• Clinical Trial of Expanded and Activated Autologous NK Cells to Treat Multiple Myeloma#1031071ClinicalTrials.gov
• Nk Cell Therapy for Recurrent Glioblastoma Multiform Patients#857728ClinicalTrials.gov
• CAR-NK Cells Production and Expansion From Patients With Lympho or Myeloproliferative Disorders and From Healthy Donors#848379ClinicalTrials.gov
• Reactivating NK Cells in Treating Refractory Head and Neck Cancer#1384956ClinicalTrials.gov
• Allogeneic Natural Killer (NK) Cell Therapy in Subjects Hospitalized for COVID-19#911684ClinicalTrials.gov
• Alloreactive NK Cells for Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)#844967ClinicalTrials.gov
• Natural Killer Cells Function in Patients With Chronic Lymphocytic Leukemia#1074238ClinicalTrials.gov
• Study of T Cells and Natural Killer Cells Expression in Patients With Immune Thrombocytopenic Purpura#1477602ClinicalTrials.gov
• NK White Blood Cells and Interleukin in Children and Young Adults With Advanced Solid Tumors#1030787ClinicalTrials.gov
• Ex Vivo Expanded NK Cells Infusion Decrease Relapse Post Hematopoietic Stem Cell Transplantation#856955ClinicalTrials.gov
• Mechanisms of tumor cell evasion from NK cell-mediated killing and advances in NK cell-based cancer immunotherapy#4574Europe PMC
• Cord Blood Natural Killer (NK) Cells in Leukemia/Lymphoma#628536ClinicalTrials.gov
• Angelica Gigas Dietary Supplements and Human Immune Cells#1245549ClinicalTrials.gov
• Inflammation, NK Cells, Antisense Protein and Exosomes, and Correlation With Immune Response During HIV Infection#893915ClinicalTrials.gov
• Androgen receptor signaling blockade enhances NK cell-mediated killing of prostate cancer cells and sensitivity to NK cell checkpoint blockade#10075bioRxiv / medRxiv
• Haploidentical Natural Killer (NK) Cells With Epratuzumab for Relapsed Acute Lymphoblastic Leukemia (ALL)#1010865ClinicalTrials.gov
• Dual-Target CLDN18.2/HER2 CAR-NK Cells for Advanced Esophageal Adenocarcinoma#872295ClinicalTrials.gov
• Assessment of Natural Killer Cells in Unexplained Recurrent Pregnancy Loss#854976ClinicalTrials.gov
• Ph I Trial of NAM NK Cells and IL-2 for Adult Pts With MM and NHL#1262854ClinicalTrials.gov
• Natural Killer (NK) Cells Following Bariatric Surgery#824775ClinicalTrials.gov
• Integrating Allogeneic NK Cells in High-risk Advanced Stage III-IV Nasopharyngeal Cancer Patients#1294279ClinicalTrials.gov
• Donor Immune Cells (TGFbi NK Cells) and Isatuximab for the Treatment of Relapsed or Refractory Multiple Myeloma#201786ClinicalTrials.gov
• The interplay between loneliness, cortisol, and NK cell function: The role of cortisol in NK cell dysfunction.#240443PubMed
• RNAseq of NK cells from patients with ovarian cancer#437545Repositório de Dados de Pesquisa da Unicamp Dataverse OAI Archive
• Dual inhibition of mTOR and calcineurin pathways mitigates missing self–induced NK cell–mediated microvascular rejection#1492741HAL (France)
• Amélioration de l’immunothérapie à base de Natural Killer (NK) : combinaison avec des anticorps monoclonaux modifiés#262170HAL (France)
• Killer-cell immunoglobulin-like receptors define a potent effector program in human γδ T cells#1312741HAL (France)
• The Role of NK Cells to Detect Blood Infection in ALL.#195359ClinicalTrials.gov
• Induced pluripotent stem cells as platforms for engineering NK cell immunotherapies.#199133NCBI PubMed Central
• CD8(+) T cell differentiation into NK-like effector cells drives transplant rejection.#295207NCBI PubMed Central